investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Programming T Cell Fates for Therapeutic Use

Luca Gattinoni

3 Collaborator(s)

Funding source

National Cancer Institute (NIH)
Together with Dr. Zehn's group we are exploring the role of microRNA-155 in CD8+ T cell responses

Related projects

Alan Rein

Interactions of APOBEC3 Proteins with Murine Leukemia Viruses

Leukaemia

Pathology Hematology and hematologic malignancies

Catherine Ju-Ying Wu

Defining the Impact of Clonal Evolution on Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies Pathology

Reuben Kapur

Role of p21 Activated Kinase in Leukemogenesis

Leukaemia

Hematology and hematologic malignancies

Elizaveta V Benevolenskaya

RBP2 Regulation Through Differential Recruitment to Genomic Loci

Leukaemia

Hematology and hematologic malignancies Pathology

Robert Kreitman

Development of Recombinant Toxins to Treat Hematologic Malignancies

Leukaemia

Hematology and hematologic malignancies

Michael R Green

Identification and Characterization of Genes that Suppress BCR-ABL+ Leukemia

Leukaemia

Pathology Hematology and hematologic malignancies

Edward W Harhaj

Mechanisms of HTLV-I Tax Mediated NF-kB Activation

Leukaemia

Hematology and hematologic malignancies Pathology

Peter Aplan

Pre-clinical Studies of Therapy for Myelodysplastic Syndrome

Leukaemia

Hematology and hematologic malignancies

Jun J Yang

ARID5B and Disparities of Childhood Leukemia

Leukaemia

Hematology and hematologic malignancies